Lipocine LPCN
NASDAQ LPCN
$2.05 -0.02 (-0.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lipocine (LPCN) Price to Earnings (2022)

Updated

Lipocine's (LPCN) Price to Earnings stood at 10.57 in Q3 2022, down 49.0% from the prior quarter.

Analysis

Lipocine (LPCN) Price to Earnings (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lipocine 11.11 Mn -56.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 10.57
Jun 30, 2022 20.71
API Access

Lipocine Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=LPCN&period=max&api_key=YOUR_API_KEY